{"related:7B2xu3_xMLMJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","url":"https://academic.oup.com/jcem/article-abstract/91/8/2892/2656354","authors":["C Durante","C Durante N Haddy","C Durante N Haddy E Baudin…"],"year":2006,"numCitations":1232,"pdf":"https://academic.oup.com/jcem/article/91/8/2892/2656354","citationUrl":"http://scholar.google.com/scholar?cites=12912085662583299564&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:7B2xu3_xMLMJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12912085662583299564&hl=en&as_sdt=0,5","publication":"academic.oup.com","p":1,"exp":1596876817851},{"title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673614604219","authors":["MS Brose","MS Brose CM Nutting","MS Brose CM Nutting B Jarzab","MS Brose CM Nutting B Jarzab R Elisei","MS Brose CM Nutting B Jarzab R Elisei S Siena…"],"year":2014,"numCitations":889,"pdf":"https://europepmc.org/articles/pmc4366116/bin/nihms669481-supplement-01.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2351956758389670746&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:WkPl5jXUoyAJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2351956758389670746&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1406470","authors":["M Schlumberger","M Schlumberger M Tahara","M Schlumberger M Tahara LJ Wirth…"],"year":2015,"numCitations":963,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1406470","citationUrl":"http://scholar.google.com/scholar?cites=4438146991178577354&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:yvUqlix3lz0J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4438146991178577354&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1209288","authors":["AL Ho","AL Ho RK Grewal","AL Ho RK Grewal R Leboeuf…"],"year":2013,"numCitations":569,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1209288","citationUrl":"http://scholar.google.com/scholar?cites=11333253916352564630&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ls1_CWTOR50J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11333253916352564630&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning","url":"https://academic.oup.com/jcem/article-abstract/91/2/498/2843346","authors":["RJ Robbins","RJ Robbins Q Wan","RJ Robbins Q Wan RK Grewal…"],"year":2006,"numCitations":554,"pdf":"https://academic.oup.com/jcem/article/91/2/498/2843346","citationUrl":"http://scholar.google.com/scholar?cites=9219796750380893617&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:sQXBv0tM838J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9219796750380893617&hl=en&as_sdt=0,5","publication":"academic.oup.com"},{"title":"Phase II trial of sorafenib in metastatic thyroid cancer","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668972/","authors":["RT Kloos","RT Kloos MD Ringel","RT Kloos MD Ringel MV Knopp","RT Kloos MD Ringel MV Knopp NC Hall…"],"year":2009,"numCitations":598,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668972/","citationUrl":"http://scholar.google.com/scholar?cites=511400549831003119&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:78udLhfcGAcJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=511400549831003119&hl=en&as_sdt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Definition and management of radioactive iodine-refractory differentiated thyroid cancer","url":"https://www.thelancet.com/journals/landia/article/PIIS2213-8587(13)70215-8/fulltext","authors":["M Schlumberger","M Schlumberger M Brose","M Schlumberger M Brose R Elisei…"],"year":2014,"numCitations":212,"citationUrl":"http://scholar.google.com/scholar?cites=1855527010274479071&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:34uNHvwnwBkJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1855527010274479071&hl=en&as_sdt=0,5","publication":"thelancet.com"},{"title":"Phase II trial of sorafenib in advanced thyroid cancer","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653134/","authors":["V Gupta"],"year":2008,"numCitations":742,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653134/","citationUrl":"http://scholar.google.com/scholar?cites=4630342351460531889&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:sX5AB9ZHQkAJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4630342351460531889&hl=en&as_sdt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas","url":"https://academic.oup.com/jcem/article-abstract/86/4/1568/2848375","authors":["MO Bernier","MO Bernier L Leenhardt","MO Bernier L Leenhardt C Hoang…"],"year":2001,"numCitations":304,"pdf":"https://academic.oup.com/jcem/article/86/4/1568/2848375","citationUrl":"http://scholar.google.com/scholar?cites=14701860427376673396&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dMIoNyqAB8wJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14701860427376673396&hl=en&as_sdt=0,5","publication":"academic.oup.com"},{"title":"Motesanib diphosphate in progressive differentiated thyroid cancer","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa075853","authors":["SI Sherman","SI Sherman LJ Wirth","SI Sherman LJ Wirth JP Droz…"],"year":2008,"numCitations":523,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa075853","citationUrl":"http://scholar.google.com/scholar?cites=14954316462243867170&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ImrSTpdniM8J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14954316462243867170&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"}]}